The Use of Mesenchymal Stromal Cells in the Treatment of Coronavirus Disease 2019

    September 2020 in “ Journal of Translational Medicine
    Maurice A. Canham, John Campbell, Joanne C. Mountford
    Image
    Studysummary This overview highlights the exploration of mesenchymal stromal cells as potential treatments for COVID-19, noting their regenerative and immunomodulatory properties for reducing ARDS severity in critically ill patients, but it provides no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results